Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0139786c899328a91c559bd8a62ba03 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c60a3c77d34e9ba346caf0a08bb96013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cacf19b80d97d4889e84b2110caef0df |
publicationDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RS-52956-B |
titleOfInvention |
CANCER TREATMENT COMPOSITIONS |
abstract |
The use of a therapeutically effective amount of abiraterone acetate or a pharmaceutically acceptable salt thereof in the preparation of a medicament for the treatment of prostate cancer in a human, wherein the medicament is prepared in combination with a therapeutically effective amount of prednisone. |
priorityDate |
2006-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |